In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

VisionCare Ophthalmic Technologies Inc.

www.visioncareinc.net

Latest From VisionCare Ophthalmic Technologies Inc.

VisionCare Anticipates Big Boost From Expanded Telescope Implant Indication

FDA approved VisionCare Ophthalmic Technologies’ Implantable Miniature Telescope to treat macular degeneration in 65- to 74-year-old patients, expanding on the original 75-and-older indication and growing the potential market by about a third.

Medical Device Reimbursement

Start-Up News

Noteworthy news from medtech start-ups. This month we profile three emerging artificial retina developers: Nano Retina, 2C Tech Corp. and LambdaVision.

Medical Device

Retinal Disease: Much Progress, Some Pain

On many fronts, 2011 was an event-filled year for the retinal disease market, beginning with the publication of the CATT trial comparing off-label intravitreal Avastin versus Lucentis for the treatment of AMD, and ending with several important milestones for device manufacturers operating in this space. But while the retinal device field is making progress in many areas, companies continue to struggle to meet shifting FDA approval requirements.

BioPharmaceutical Medical Device

2C Tech Corp. Inc.

2C Tech Corp. is developing a non-surgical, nanotechnology-based artificial retinal prostheses designed to overcome the limitations of current, implanted silicon chips and to operate at the cellular level over the entire retina to preserve sight. The start-up’s injectable SeeQ device converts ambient light to electrical energy. As photoreceptors are stimulated by the electrical charge, they release growth factors beneficial for retinal cell preservation.

Medical Device Nanotechnology
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
  • Therapeutic Areas
  • Ophthalmic
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • VisionCare Ophthalmic Technologies Inc.
  • Senior Management
  • Allen W Hill, Pres. & CEO
    Eli Aharoni, VP, R&D
    Chet Kumar, VP, Bus. & Mkt. Dev.
  • Contact Info
  • VisionCare Ophthalmic Technologies Inc.
    Phone: (408) 872-9393
    14395 Saratoga Ave.
    Ste. 150
    Saratoga, CA 95070
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register